| David Ashir Jawahar, MD | |
|
807 S Bradford St, Dover, DE 19904-4137 | |
| (302) 674-7155 | |
| (302) 674-7156 |
| Full Name | David Ashir Jawahar |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 37 Years |
| Location | 807 S Bradford St, Dover, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306828330 | NPI | - | NPPES |
| 0001010401 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | C10005844 (Delaware) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | C10005844 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayhealth Hospital, Kent Campus | Dover, DE | Hospital |
| Bayhealth Hospital, Sussex Campus | Milford, DE | Hospital |
| Christiana Hospital | Newark, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kent Pulmonary Associates | 8921018334 | 2 |
News Archive
Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system ("CNS"), including fibromyalgia syndrome ("FM") and post-traumatic stress disorder ("PTSD"), has announced the effectiveness of a company name change to Tonix Pharmaceuticals Holding Corp. and the commencement of trading under the stock symbol "TNXP".
A single strand of plant or animal DNA may contain tens of thousands of genes, each programmed to produce a specific protein essential for the growth or survival of the organism. The challenge for geneticists is to isolate individual genes and determine their function – a painstaking process often requiring years of laboratory trial and error.
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8 billion respiratory market, today announced that its Annual Report has been filed with the OTC Markets, while auditors have completed and filed required restatements needed to return to "fully reporting" status.
A large study jointly led by Queen Mary University of London and UCL aims to identify people at risk of developing Parkinson's, years before the condition is currently detected, with a view to treating and alleviating it at a much earlier stage.
In just a few short months, hospitals across the country will start their annual push to make sure their workers get vaccinated against influenza, to protect themselves and others. Memories of the last flu season – one of the worst in years – still linger.
› Verified 3 days ago
| Entity Name | Kent Pulmonary Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801801675 PECOS PAC ID: 8921018334 Enrollment ID: O20060501000219 |
News Archive
Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system ("CNS"), including fibromyalgia syndrome ("FM") and post-traumatic stress disorder ("PTSD"), has announced the effectiveness of a company name change to Tonix Pharmaceuticals Holding Corp. and the commencement of trading under the stock symbol "TNXP".
A single strand of plant or animal DNA may contain tens of thousands of genes, each programmed to produce a specific protein essential for the growth or survival of the organism. The challenge for geneticists is to isolate individual genes and determine their function – a painstaking process often requiring years of laboratory trial and error.
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8 billion respiratory market, today announced that its Annual Report has been filed with the OTC Markets, while auditors have completed and filed required restatements needed to return to "fully reporting" status.
A large study jointly led by Queen Mary University of London and UCL aims to identify people at risk of developing Parkinson's, years before the condition is currently detected, with a view to treating and alleviating it at a much earlier stage.
In just a few short months, hospitals across the country will start their annual push to make sure their workers get vaccinated against influenza, to protect themselves and others. Memories of the last flu season – one of the worst in years – still linger.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Ashir Jawahar, MD 807 S Bradford St, Dover, DE 19904-4137 Ph: (302) 674-7155 | David Ashir Jawahar, MD 807 S Bradford St, Dover, DE 19904-4137 Ph: (302) 674-7155 |
News Archive
Tonix Pharmaceuticals Holding Corp., a specialty pharmaceutical company developing therapies for challenging disorders of the central nervous system ("CNS"), including fibromyalgia syndrome ("FM") and post-traumatic stress disorder ("PTSD"), has announced the effectiveness of a company name change to Tonix Pharmaceuticals Holding Corp. and the commencement of trading under the stock symbol "TNXP".
A single strand of plant or animal DNA may contain tens of thousands of genes, each programmed to produce a specific protein essential for the growth or survival of the organism. The challenge for geneticists is to isolate individual genes and determine their function – a painstaking process often requiring years of laboratory trial and error.
Ingen Technologies, Inc., an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8 billion respiratory market, today announced that its Annual Report has been filed with the OTC Markets, while auditors have completed and filed required restatements needed to return to "fully reporting" status.
A large study jointly led by Queen Mary University of London and UCL aims to identify people at risk of developing Parkinson's, years before the condition is currently detected, with a view to treating and alleviating it at a much earlier stage.
In just a few short months, hospitals across the country will start their annual push to make sure their workers get vaccinated against influenza, to protect themselves and others. Memories of the last flu season – one of the worst in years – still linger.
› Verified 3 days ago
Theodore Conrad Ang Tan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 810 New Burton Rd, Suite 3, Dover, DE 19904 Phone: 302-730-0554 Fax: 302-730-1175 | |
Francis Lim, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 419-276-1194 | |
Safwan Muhammad, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 640 S State St, Dover, DE 19901 Phone: 879-022-5410 | |
Dr. Wai Wai Lin, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1058 S Governors Ave Ste 101, Dover, DE 19904 Phone: 302-401-1500 Fax: 302-672-6450 | |
Abdul Muhaymin Siyal, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 720 S Queen St, Dover, DE 19904 Phone: 302-734-7834 Fax: 302-734-7847 | |
Dr. Daniel L. Fisher, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 333 Red Tail Dr, Dover, DE 19904 Phone: 302-943-8040 | |
Dr. Manmeet Brar, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1198 S Governors Ave Ste B100, Dover, DE 19904 Phone: 302-734-3227 Fax: 302-734-0391 |